Midterm Echocardiographic Outcomes of Minimally Invasive Mitral Valve Surgery in Patients With Previous Cardiac Surgery

<h2>Abstract</h2><h3>Background</h3> Minimally invasive mitral valve repair (MVr) and mitral valve replacement (MVR) after previous sternotomy are relatively uncommon. This study reports midterm outcomes at a single institution. <h3>Methods</h3> All patients with a history of previous cardiac surgery who underwent minimally invasive MVr and MVR with hypothermic fibrillatory arrest at our institution (Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada) between 2006 and 2024 were included. Follow-up echocardiographic reports were reviewed at 1 year, 1 to 3 years, 3 to 5 years, and 5+ years. Primary outcomes included postoperative complications, all-cause mortality, and rates of grade 3 to 4 mitral regurgitation at follow-up. <h3>Results</h3> A total of 31 patients met the inclusion criteria (25.8% female patients), and their median age was 64 years. A total of 18 patients underwent MVR, and 13 underwent MVr. The most common previous cardiac operations were aortic valve replacement (AVR), coronary artery bypass graft, and MVR. All redo procedures were completed using hypothermic fibrillatory arrest (mean, 23.3 [2.5] °C; median duration, 143.0 minutes [interquartile range, 110.5-175.0 minutes]) for myocardial protection. The 30-day, 5-year, and 10-year all-cause mean mortality rates were 0.0% (0.0%), 12.9% (6.0%), and 25.8% (7.9%), respectively. Patients with previous AVR with or without ascending aortic replacement represented 50% of total deaths. Overall, 4 (12.9%) patients had recurrent grade 3 to 4 mitral regurgitation: 3 died, and 1 had subsequent double-redo MVR. <h3>Conclusions</h3> Our study demonstrates low perioperative mortality rates, thus implying the safety of fibrillatory arrest for myocardial protection in redo minimally invasive MVr and MVR. We also identified that patients with AVR with or without ascending aortic replacement face a higher midterm risk, given the technical difficulty of operating with fibrillatory arrest on the anterolateral portion of the mitral valve when the aortic annulus or root is inflexible.

Authors

Institutions

Publication Details

Journal
Annals of Thoracic Surgery Short Reports
Published
2025-12-01
DOI
https://doi.org/10.1016/j.atssr.2025.11.007
Primary Topic
Cardiac and Coronary Surgery Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Midterm Echocardiographic Outcomes of Minimally Invasive Mitral Valve Surgery in Patients With Previous Cardiac Surgery

Rosalind Groenewoud, Durr Al-Hakim, Nicolas Mourad, Richard Cook
Annals of Thoracic Surgery Short Reports
Cardiac and Coronary Surgery Techniques
article

Midterm Echocardiographic Outcomes of Minimally Invasive Mitral Valve Surgery in Patients With Previous Cardiac Surgery

Rosalind Groenewoud, Durr Al-Hakim, Nicolas Mourad, Richard Cook
article en

Abstract

<h2>Abstract</h2><h3>Background</h3> Minimally invasive mitral valve repair (MVr) and mitral valve replacement (MVR) after previous sternotomy are relatively uncommon. This study reports midterm outcomes at a single institution. <h3>Methods</h3> All patients with a history of previous cardiac surgery who underwent minimally invasive MVr and MVR with hypothermic fibrillatory arrest at our institution (Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada) between 2006 and 2024 were included. Follow-up echocardiographic reports were reviewed at 1 year, 1 to 3 years, 3 to 5 years, and 5+ years. Primary outcomes included postoperative complications, all-cause mortality, and rates of grade 3 to 4 mitral regurgitation at follow-up. <h3>Results</h3> A total of 31 patients met the inclusion criteria (25.8% female patients), and their median age was 64 years. A total of 18 patients underwent MVR, and 13 underwent MVr. The most common previous cardiac operations were aortic valve replacement (AVR), coronary artery bypass graft, and MVR. All redo procedures were completed using hypothermic fibrillatory arrest (mean, 23.3 [2.5] °C; median duration, 143.0 minutes [interquartile range, 110.5-175.0 minutes]) for myocardial protection. The 30-day, 5-year, and 10-year all-cause mean mortality rates were 0.0% (0.0%), 12.9% (6.0%), and 25.8% (7.9%), respectively. Patients with previous AVR with or without ascending aortic replacement represented 50% of total deaths. Overall, 4 (12.9%) patients had recurrent grade 3 to 4 mitral regurgitation: 3 died, and 1 had subsequent double-redo MVR. <h3>Conclusions</h3> Our study demonstrates low perioperative mortality rates, thus implying the safety of fibrillatory arrest for myocardial protection in redo minimally invasive MVr and MVR. We also identified that patients with AVR with or without ascending aortic replacement face a higher midterm risk, given the technical difficulty of operating with fibrillatory arrest on the anterolateral portion of the mitral valve when the aortic annulus or root is inflexible.

Annals of Thoracic Surgery Short Reports
University of British Columbia (CA), Vancouver General Hospital (CA)
Openalex Percentile: Top 42%
Cardiac and Coronary Surgery Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.